103 related articles for article (PubMed ID: 11438504)
1. Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis.
Jonsson JR; Clouston AD; Ando Y; Kelemen LI; Horn MJ; Adamson MD; Purdie DM; Powell EE
Gastroenterology; 2001 Jul; 121(1):148-55. PubMed ID: 11438504
[TBL] [Abstract][Full Text] [Related]
2. Evidence for modulation of pericryptal sheath myofibroblasts in rat descending colon by transforming growth factor beta and angiotensin II.
Thiagarajah JR; Griffiths NM; Pedley KC; Naftalin RJ
BMC Gastroenterol; 2002; 2():4. PubMed ID: 11872151
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme 2 alleviates liver fibrosis through the renin-angiotensin system.
Zhao BW; Chen YJ; Zhang RP; Chen YM; Huang BW
World J Gastroenterol; 2024 Feb; 30(6):607-609. PubMed ID: 38463024
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous Epiretinal Membrane Resolution and Angiotensin Receptor Blockers: Case Observation, Literature Review and Perspectives.
Confalonieri F; Lumi X; Petrovski G
Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509613
[TBL] [Abstract][Full Text] [Related]
5. Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure.
Inciardi RM; Mantovani A; Targher G
Curr Heart Fail Rep; 2023 Aug; 20(4):308-319. PubMed ID: 37402108
[TBL] [Abstract][Full Text] [Related]
6. Endotoxemia and Gastrointestinal Cancers: Insight into the Mechanisms Underlying a Dangerous Relationship.
Manilla V; Di Tommaso N; Santopaolo F; Gasbarrini A; Ponziani FR
Microorganisms; 2023 Jan; 11(2):. PubMed ID: 36838231
[TBL] [Abstract][Full Text] [Related]
7. Topical captopril: a promising treatment for secondary lymphedema.
Brown S; Nores GDG; Sarker A; Ly C; Li C; Park HJ; Hespe GE; Gardenier J; Kuonqui K; Campbell A; Shin J; Kataru RP; Aras O; Mehrara BJ
Transl Res; 2023 Jul; 257():43-53. PubMed ID: 36736951
[TBL] [Abstract][Full Text] [Related]
8. Consumption of the cell-free or heat-treated fractions of a pitched kefir confers some but not all positive impacts of the corresponding whole kefir.
Bourrie BCT; Forgie AJ; Ju T; Richard C; Cotter PD; Willing BP
Front Microbiol; 2022; 13():1056526. PubMed ID: 36504827
[TBL] [Abstract][Full Text] [Related]
9. Promising results of captopril in improving knee arthrofibrosis and cartilage status: an animal model study.
Hashemi SA; Azad A; Erfani A; Shahriarirad R; Azarpira N
J Exp Orthop; 2022 Jul; 9(1):72. PubMed ID: 35900609
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation.
Crouchet E; Li S; Sojoodi M; Bandiera S; Fujiwara N; El Saghire H; Zhu S; Qian T; Rasha FA; Del Zompo F; Barrett SC; Schaeffer E; Oudot MA; Ponsolles C; Durand SC; Ghoshal S; Arora G; Giannone F; Chung RT; Slovic N; Van Renne N; Felli E; Pessaux P; Lupberger J; Pochet N; Schuster C; Tanabe KK; Hoshida Y; Fuchs BC; Baumert TF
JCI Insight; 2022 Jul; 7(13):. PubMed ID: 35801591
[TBL] [Abstract][Full Text] [Related]
11. Renin-Angiotensin System in Liver Metabolism: Gender Differences and Role of Incretins.
Mastoor Z; Diz-Chaves Y; González-Matías LC; Mallo F
Metabolites; 2022 May; 12(5):. PubMed ID: 35629915
[TBL] [Abstract][Full Text] [Related]
12. Beneficial Effects of Dietary Nitrite on a Model of Nonalcoholic Steatohepatitis Induced by High-Fat/High-Cholesterol Diets in SHRSP5/Dmcr Rats: A Preliminary Study.
Sonoda K; Kono Y; Kitamori K; Ohtake K; Shiba S; Kasono K; Kobayashi J
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328352
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis.
Kumar V; Xin X; Ma J; Tan C; Osna N; Mahato RI
Adv Drug Deliv Rev; 2021 Sep; 176():113888. PubMed ID: 34314787
[TBL] [Abstract][Full Text] [Related]
14. Management of Cirrhotic Ascites under the Add-on Administration of Tolvaptan.
Adachi T; Takeuchi Y; Takaki A; Oyama A; Wada N; Onishi H; Shiraha H; Okada H
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070416
[TBL] [Abstract][Full Text] [Related]
15. Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options.
Rajapaksha IG; Gunarathne LS; Angus PW; Herath CB
J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33670126
[TBL] [Abstract][Full Text] [Related]
16. Treatments for NAFLD: State of Art.
Mantovani A; Dalbeni A
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652942
[TBL] [Abstract][Full Text] [Related]
17. Cirrhotic portal hypertension: From pathophysiology to novel therapeutics.
Gunarathne LS; Rajapaksha H; Shackel N; Angus PW; Herath CB
World J Gastroenterol; 2020 Oct; 26(40):6111-6140. PubMed ID: 33177789
[TBL] [Abstract][Full Text] [Related]
18. Effect of Renin-Angiotensin System Blockage in Patients with Acute Respiratory Distress Syndrome: A Retrospective Case Control Study.
Kim J; Choi SM; Lee J; Park YS; Lee CH; Yim JJ; Yoo CG; Kim YW; Han SK; Lee SM
Korean J Crit Care Med; 2017 May; 32(2):154-163. PubMed ID: 31723629
[TBL] [Abstract][Full Text] [Related]
19. Hepatoprotective effects of vicenin-2 and scolymoside through the modulation of inflammatory pathways.
Lee IC; Bae JS
J Nat Med; 2020 Jan; 74(1):90-97. PubMed ID: 31350693
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
